BG106959A - Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate - Google Patents
Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylateInfo
- Publication number
- BG106959A BG106959A BG106959A BG10695902A BG106959A BG 106959 A BG106959 A BG 106959A BG 106959 A BG106959 A BG 106959A BG 10695902 A BG10695902 A BG 10695902A BG 106959 A BG106959 A BG 106959A
- Authority
- BG
- Bulgaria
- Prior art keywords
- cyclopentyloxy
- monohydrate
- methoxyphenyl
- cis
- cyano
- Prior art date
Links
- 150000004682 monohydrates Chemical class 0.000 title abstract 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-M cyclohexanecarboxylate Chemical compound [O-]C(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-M 0.000 title 1
- 229910003002 lithium salt Inorganic materials 0.000 abstract 1
- 159000000002 lithium salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17812900P | 2000-01-26 | 2000-01-26 | |
| PCT/US2001/001487 WO2001055094A1 (en) | 2000-01-26 | 2001-01-18 | Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG106959A true BG106959A (en) | 2003-05-30 |
Family
ID=22651319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG106959A BG106959A (en) | 2000-01-26 | 2002-07-26 | Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6699903B2 (cs) |
| EP (1) | EP1250313B1 (cs) |
| JP (1) | JP2003520842A (cs) |
| KR (1) | KR20020073183A (cs) |
| CN (1) | CN1157371C (cs) |
| AP (1) | AP1432A (cs) |
| AR (1) | AR027273A1 (cs) |
| AT (1) | ATE344235T1 (cs) |
| AU (1) | AU3282201A (cs) |
| BG (1) | BG106959A (cs) |
| BR (1) | BR0107709A (cs) |
| CA (1) | CA2397758A1 (cs) |
| CO (1) | CO5300517A1 (cs) |
| CY (1) | CY1108515T1 (cs) |
| CZ (1) | CZ20022590A3 (cs) |
| DE (1) | DE60124221T2 (cs) |
| DK (1) | DK1250313T3 (cs) |
| DZ (1) | DZ3285A1 (cs) |
| EA (1) | EA200200791A1 (cs) |
| EG (1) | EG24065A (cs) |
| ES (1) | ES2273804T3 (cs) |
| HK (1) | HK1051030A1 (cs) |
| HU (1) | HUP0204150A3 (cs) |
| IL (1) | IL150400A0 (cs) |
| MA (1) | MA25652A1 (cs) |
| MX (1) | MXPA02007300A (cs) |
| MY (1) | MY122802A (cs) |
| NO (1) | NO20023378L (cs) |
| NZ (1) | NZ519799A (cs) |
| OA (1) | OA12159A (cs) |
| PE (1) | PE20011040A1 (cs) |
| PL (1) | PL356832A1 (cs) |
| PT (1) | PT1250313E (cs) |
| SK (1) | SK10942002A3 (cs) |
| WO (1) | WO2001055094A1 (cs) |
| ZA (1) | ZA200205925B (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0011802D0 (en) * | 2000-05-16 | 2000-07-05 | Smithkline Beecham | Method for enhancing cognitive function |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU225869B1 (en) * | 1992-04-02 | 2007-11-28 | Smithkline Beecham Corp | Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them |
| UA67753C2 (uk) * | 1997-10-10 | 2004-07-15 | Смітклайн Бічам Корпорейшн | Спосіб отримання заміщених 4-феніл-4-ціанциклогексанових кислот |
-
2001
- 2001-01-18 EP EP01904886A patent/EP1250313B1/en not_active Expired - Lifetime
- 2001-01-18 SK SK1094-2002A patent/SK10942002A3/sk unknown
- 2001-01-18 WO PCT/US2001/001487 patent/WO2001055094A1/en not_active Ceased
- 2001-01-18 KR KR1020027009545A patent/KR20020073183A/ko not_active Ceased
- 2001-01-18 AP APAP/P/2002/002566A patent/AP1432A/en active
- 2001-01-18 ES ES01904886T patent/ES2273804T3/es not_active Expired - Lifetime
- 2001-01-18 MX MXPA02007300A patent/MXPA02007300A/es active IP Right Grant
- 2001-01-18 DK DK01904886T patent/DK1250313T3/da active
- 2001-01-18 HK HK03101828.3A patent/HK1051030A1/zh unknown
- 2001-01-18 IL IL15040001A patent/IL150400A0/xx unknown
- 2001-01-18 AT AT01904886T patent/ATE344235T1/de not_active IP Right Cessation
- 2001-01-18 CA CA002397758A patent/CA2397758A1/en not_active Abandoned
- 2001-01-18 PT PT01904886T patent/PT1250313E/pt unknown
- 2001-01-18 PL PL01356832A patent/PL356832A1/xx not_active IP Right Cessation
- 2001-01-18 EA EA200200791A patent/EA200200791A1/ru unknown
- 2001-01-18 BR BR0107709-0A patent/BR0107709A/pt not_active IP Right Cessation
- 2001-01-18 US US10/181,865 patent/US6699903B2/en not_active Expired - Fee Related
- 2001-01-18 HU HU0204150A patent/HUP0204150A3/hu unknown
- 2001-01-18 JP JP2001555036A patent/JP2003520842A/ja not_active Withdrawn
- 2001-01-18 DE DE60124221T patent/DE60124221T2/de not_active Expired - Lifetime
- 2001-01-18 OA OA1200200211A patent/OA12159A/en unknown
- 2001-01-18 DZ DZ013285A patent/DZ3285A1/fr active
- 2001-01-18 AU AU32822/01A patent/AU3282201A/en not_active Abandoned
- 2001-01-18 CN CNB018040160A patent/CN1157371C/zh not_active Expired - Fee Related
- 2001-01-18 CZ CZ20022590A patent/CZ20022590A3/cs unknown
- 2001-01-18 NZ NZ519799A patent/NZ519799A/en unknown
- 2001-01-23 MY MYPI20010322A patent/MY122802A/en unknown
- 2001-01-24 EG EG20010070A patent/EG24065A/xx active
- 2001-01-24 AR ARP010100298A patent/AR027273A1/es unknown
- 2001-01-25 PE PE2001000081A patent/PE20011040A1/es not_active Application Discontinuation
- 2001-01-26 CO CO01005892A patent/CO5300517A1/es not_active Application Discontinuation
-
2002
- 2002-07-12 NO NO20023378A patent/NO20023378L/no not_active Application Discontinuation
- 2002-07-24 ZA ZA200205925A patent/ZA200205925B/en unknown
- 2002-07-24 MA MA26744A patent/MA25652A1/fr unknown
- 2002-07-26 BG BG106959A patent/BG106959A/xx unknown
-
2007
- 2007-01-10 CY CY20071100034T patent/CY1108515T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2260337A1 (en) | Therapeutic agents | |
| IL158485A0 (en) | Spiropyrazole compounds | |
| MXPA04006976A (es) | Chicle con el centro relleno que contiene calcio. | |
| CA2379614A1 (en) | Fragrance emitting device | |
| ZA200205193B (en) | Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl. | |
| WO2004011453A3 (en) | Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles | |
| MY122829A (en) | Linezolid-crystal form ii | |
| EP1466898A4 (en) | INHIBITORS OF THE PRODUCTION / SEPARATION OF BETA-AMYLOIDS PROTEINS | |
| DE60216233D1 (en) | Carbolinderivate | |
| EP1975164A3 (en) | Octahydrobenzimidazolone compounds as analgetics | |
| CA2360024A1 (en) | Process for the preparation of non-steroidal glucocorticoid receptor modulators | |
| EP2039693A3 (en) | Novel synthesis of irbesartan | |
| AU2001266575A1 (en) | Chemical compounds | |
| IL154789A0 (en) | Process for the preparation of gabapentin | |
| PL367298A1 (en) | Process for the production of beraprost and its salts | |
| TW427990B (en) | Process for preparing substituted oxazinoindole carboxamides and the intermediates therefor | |
| AP1432A (en) | Monohydrate of Cis-Lithium-Cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate. | |
| AU9069201A (en) | Interheteroaryl 7-oxabicyclic (2.2.1)heptane oxazoles as prostaglandin F<sub>2alpha</sub> antagonists | |
| BG103320A (en) | Method for the alkylating hindered sulphonamides | |
| MXPA04004937A (es) | Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles. | |
| NZ515685A (en) | Use of riluzole for the treatment of multiple sclerosis | |
| WO1999046245A3 (en) | PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL | |
| BG103651A (en) | Compounds and methods for the preparation of substituted 4-phenyl-4-cyanocyclohexanoic acids | |
| IL156768A0 (en) | Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine | |
| HRP970399B1 (en) | Intermediates for the preparation of 2-imidazoline-5-ones |